Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page
- CheckyesterdayChange DetectedTwo new literature citations were added to the study record, including Hansen et al. and Wong & Yee, documenting recent research on T cell responses and polyomavirus-positive Merkel cell carcinoma.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedFooter now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5; this reflects a site-wide version update rather than a change to the study details.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedAn updated revision tag from v3.6.4 to v3.6.5 is displayed on the page, indicating a newer version of the study document.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page's revision history now shows a new revision tag, v3.6.4. The prior revision tag, v3.6.3, has been removed, indicating an update to the document version.SummaryDifference0.0%

- Check72 days agoChange DetectedThe revision label on the page has been updated from v3.6.2 to v3.6.3, indicating a minor version update to the page metadata. This change does not reflect a substantive update to the study content or visible information.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, signaling a backend or CMS update with no visible changes to study information.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.